These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12860005)

  • 1. Immunotherapeutic potential of NK and NKT cell lines in hematopoietic malignancies.
    Hu Z
    Leuk Res; 2003 Oct; 27(10):879-81. PubMed ID: 12860005
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer Immunotherapy by coordinated stimulation of innate lymphocytes (NK and NKT cells).
    Fujii S
    Rinsho Ketsueki; 2009 May; 50(5):364-74. PubMed ID: 19483396
    [No Abstract]   [Full Text] [Related]  

  • 3. The Role of Natural Killer Cells as a Platform for Immunotherapy in Pediatric Cancers.
    Kimpo MS; Oh B; Lee S
    Curr Oncol Rep; 2019 Sep; 21(10):93. PubMed ID: 31502008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically modified immune cells for cancer immunotherapy.
    Jiang L; Wang W
    Sci China Life Sci; 2018 Oct; 61(10):1277-1279. PubMed ID: 30276708
    [No Abstract]   [Full Text] [Related]  

  • 5. Reformation in chimeric antigen receptor based cancer immunotherapy: Redirecting natural killer cell.
    Lin C; Zhang J
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):200-215. PubMed ID: 29378229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Not Available].
    Caux C; Bay JO
    Bull Cancer; 2018 Dec; 105 Suppl 2():S133-S134. PubMed ID: 30686351
    [No Abstract]   [Full Text] [Related]  

  • 7. Pioneering Adoptive Immunotherapy with Natural Killer Cells.
    Grzywacz B
    Stem Cells Dev; 2019 Jun; 28(11):715-716. PubMed ID: 31081719
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent progress in and challenges in cellular therapy using NK cells for hematological malignancies.
    Tanaka J; Miller JS
    Blood Rev; 2020 Nov; 44():100678. PubMed ID: 32229065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical applications of natural killer T cell-based immunotherapy for cancer.
    Motohashi S; Nakayama T
    Cancer Sci; 2008 Apr; 99(4):638-45. PubMed ID: 18294290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoid reconstruction and vaccines.
    Gress RE; Komanduri KV; Einsele H; Cooper LJ
    Biol Blood Marrow Transplant; 2007 Jan; 13(1 Suppl 1):17-22. PubMed ID: 17222765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK cells as adoptive cellular therapy for hematological malignancies: Advantages and hurdles.
    Caruso S; De Angelis B; Carlomagno S; Del Bufalo F; Sivori S; Locatelli F; Quintarelli C
    Semin Hematol; 2020 Oct; 57(4):175-184. PubMed ID: 33256910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invariant natural killer T cells in immune surveillance and tumor immunotherapy: perspectives and potentials.
    Haeryfar SM
    Arch Iran Med; 2008 Mar; 11(2):186-95. PubMed ID: 18298297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex-vivo expansion of NK cells: what is the priority--high yield or high purity?
    Berg M; Childs R
    Cytotherapy; 2010 Dec; 12(8):969-70. PubMed ID: 21073262
    [No Abstract]   [Full Text] [Related]  

  • 15. NK cells and Immunotherapy.
    Tian Z
    Semin Immunol; 2017 Jun; 31():1-2. PubMed ID: 28985906
    [No Abstract]   [Full Text] [Related]  

  • 16. T-cell-associated cellular immunotherapy for lung cancer.
    Li K; Zhang Q; Zhang Y; Yang J; Zheng J
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1249-58. PubMed ID: 25381064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
    Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
    Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas.
    Crowe NY; Smyth MJ; Godfrey DI
    J Exp Med; 2002 Jul; 196(1):119-27. PubMed ID: 12093876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular therapy for cancer: let there be light.
    Brenner MK
    Tissue Antigens; 2012 Jan; 79(1):1-3. PubMed ID: 22150365
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunotherapeutic approaches for hematologic malignancies.
    Caligiuri MA; Velardi A; Scheinberg DA; Borrello IM
    Hematology Am Soc Hematol Educ Program; 2004; ():337-53. PubMed ID: 15561691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.